Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil Injection, Usp) 5 G/100 Ml (50 Mg/ml) Due to Particulate Matter

Teva Parenteral Medicines today announced a voluntary recall of eight lots of Adrucil® (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Product Images
Click a thumbnail to see full size image (FDA image source)
  • Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil Injection, Usp) 5 G/100 Ml (50 Mg/ml) Due to Particulate Matter
  • Teva Parenteral Medicines Initiates Voluntary Nationwide Recall of Select Lots of Adrucil® (fluorouracil Injection, Usp) 5 G/100 Ml (50 Mg/ml) Due to Particulate Matter
 
 
comments powered by Disqus